Study title: A Randomized, Multi-Cohort Phase II Trial of Temozolomide and Atezolizumab
as Second Line Treatment for Small Cell Lung Cancer
- Open to Accrual at:
- Learn more
Study Contact: studies@hoosiercancer.org; 317-921-2050
Study title: A Randomized, Multi-Cohort Phase II Trial of Temozolomide and Atezolizumab
as Second Line Treatment for Small Cell Lung Cancer
Study Contact: studies@hoosiercancer.org; 317-921-2050
© 2023 All rights reserved.
Big Ten Cancer Research Consortium
7676 Interactive Way, Suite 120, Indianapolis, IN 46278
Subscribe to the Big Ten CRC Newsletter
Twitter
Facebook
YouTube